Leber Congenital Amaurosis clinical trials

Explore recruiting leber congenital amaurosis clinical trials.

Recruiting leber congenital amaurosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Leber Congenital Amaurosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Double-Masked, Randomized, Placebo-Controlled, Paired Eye Study to Evaluate the Efficacy, Safety and Tolerability of Sepofarsen in Subjects with Leber Congenital Amaurosis (LCA) due to the c.2991+1655A>G (p.Cys998X) Mutation in the CEP290 Gene

Netherlands, Belgium, France, Germany, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Leber Congenital Amaurosis trials by city

Leber Congenital Amaurosis in Toronto Leber Congenital Amaurosis in Vancouver Leber Congenital Amaurosis in Montreal Leber Congenital Amaurosis in Calgary Leber Congenital Amaurosis in Edmonton Leber Congenital Amaurosis in Ottawa Leber Congenital Amaurosis in Winnipeg Leber Congenital Amaurosis in Quebec City Leber Congenital Amaurosis in Hamilton Leber Congenital Amaurosis in Kitchener Leber Congenital Amaurosis in London Leber Congenital Amaurosis in Halifax Leber Congenital Amaurosis in New York Leber Congenital Amaurosis in Los Angeles Leber Congenital Amaurosis in Chicago Leber Congenital Amaurosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease